Chesapeake IRB Announces Acquisition of Compass IRB

Feb 02, 2016, 12:21 ET from Chesapeake IRB

COLUMBIA, Md., Feb. 2, 2016 /PRNewswire/ -- Chesapeake IRB ("Chesapeake"), the leading technology enabled independent institutional review board ("IRB") serving the clinical research industry, announced it has acquired Compass IRB ("Compass") located in Mesa, AZ.

The Compass IRB acquisition provides Chesapeake with additional AAHRPP accredited review capacity and a talented staff that broadens our geographic presence according to Jeff Wendel, President and CEO of Chesapeake IRB.

"Compass shares our commitment to human subject protection, customer service and regulatory compliance," said Jeff Wendel. "Adding Compass to the Chesapeake team expands our ability to serve clients who value efficient, quality-focused IRB reviews."

"We are excited to join a respected, growing industry leader like Chesapeake. Their superior cloud based IRB platform, CIRBI, will enable us to easily integrate our operations," said Matt Baker, President and founder of Compass IRB.

About Chesapeake IRB

Chesapeake IRB, a Linden Capital Partners portfolio company, has been providing independent IRB services for major pharmaceutical companies, biotech and medical device companies, universities, individual researchers, academic medical centers, and hospital systems since 1993. Chesapeake IRB earned AAHRPP accreditation in 2004 and was accredited for a fourth time in June 2015.

Chesapeake IRB offers a unique 21 CFR Part 11 compliant, electronic IRB platform ("CIRBI"), which is a fully transparent, paperless, and cloud-based IRB management platform on which all IRB submissions and management tasks are performed, documented, and available for audit purposes, 24/7. CIRBI enables its staff to better serve its research partners with prompt reviews, resulting in faster subject enrollments. For more information, please visit www.chesapeakeirb.com.

About Linden Capital Partners

Linden Capital Partners is Chicago-based private equity firm focused exclusively in the healthcare and life sciences industries. For more information, please visit www.lindenllc.com.

CONTACT: Ruth Boulter, 1-609-7318786, rboulter@chesapeakeirb.com, www.chesapeakeirb.com

 

SOURCE Chesapeake IRB



RELATED LINKS

http://www.chesapeakeirb.com